DEBUG: PAGE=domain, TITLE=Life Sciences,ID=1609,TEMPLATE=subprogram
toggle expanded view
programcode = HAILSC
programid = 334
database = f
alerts = t
neat = t
vendors = t
forecasting = f
confidence = f
definitions = f

Search within: Life Sciences:

Access our analyst expertise:

Only NelsonHall clients who are logged in have access to our analysts and advisors for their expert advice and opinion.

To find out more about how NelsonHall's analysts and sourcing advisors can assist you with your strategy and engagements, please contact our sales department here.

Subscribe to blogs & alerts:

manage email alerts using the form below, in order to be notified via email whenever we publish new content:

has Database = f has Confidence = f -- IGNORED

Pharmaceuticals/Life Sciences Operational Transformation

Market Analysis

by Alisa Samoylova

published on Feb 09, 2022

Access to this report is restricted to logged in clients with access. Login to get full access

Report Overview:

NelsonHall’s market analysis of the global pharmaceuticals/life sciences operational transformation services market consists of 49-pages. 

Who is this Report for:

NelsonHall’s “Pharmaceuticals/Life Sciences Operational Transformation” report is a comprehensive market assessment report designed for:

  • Sourcing managers, monitoring the capabilities of existing suppliers of pharmaceuticals/life sciences operational transformation services, and identifying vendor suitability for operational transformation services RFPs
  • Vendor marketing, sales, and business managers looking to benchmark themselves against their peers
  • Financial analysts and investors specializing in the pharmaceuticals/life sciences services sector.

Scope of this Report:

The report analyzes the worldwide market for pharmaceuticals/life sciences operational transformation services and addresses the following questions:

  • What is the market size and projected growth for the global pharmaceuticals/life sciences operational transformation services market?
  • What are the top drivers for adopting pharmaceuticals/life sciences operational transformation services?
  • What are the benefits currently achieved by users of pharmaceuticals/life sciences operational transformation services?
  • What factors inhibit user adoption of pharmaceuticals/life sciences operational transformation services?
  • What pricing mechanisms are typically used within pharmaceuticals/life sciences operational transformation services?
  • What combination of services is typically provided within pharmaceuticals/life sciences operational transformation services contracts, and what new services are being added?
  • What is the current pattern of the delivery location used for pharmaceuticals/life sciences operational transformation services, and how is this changing?
  • What services are delivered from onshore and which from offshore?
  • What are the challenges and success factors within pharmaceuticals/life sciences operational transformation services? 

Key Findings & Highlights:

NelsonHall’s Pharmaceuticals/Life Sciences Operational Transformation Report focuses on how vendors delivering industry-specific services to pharmaceuticals/life sciences clients meet their requirements.

Some large organizations already have experience working with leading vendors to support their pharmaceuticals/life sciences operational transformation activities. However, many organizations are now recognizing that they need to introduce changes and undertake widespread transformation programs of their pharmaceuticals and life sciences operational activities, programs that might include reimagining and standardizing processes, enhancing user journeys, utilizing advanced analytics, intelligent automation, AI/ML, and other new technologies.

Login to get full access:

Pharmaceuticals/Life Sciences Operational Transformation 2022

published 2022-02-03 | Project by Alisa Samoylova

This NelsonHall Vendor Evaluation & Assessment Tool (NEAT) analyzes the performance of vendors offering operational transformation services in the pharmaceuticals/life sciences sector. The NEAT tool allows strategic sourcing managers to assess the capability of vendors across a range of criteria and business situations and identify the best performing vendors overall, and with specific capability in research & manufacturing support and in commercial operations & supply chain. Vendors evaluated are: Atos, Genpact, Infostretch, Tech Mahindra, and Wipro. To find out more, contact Guy Saunders at [email protected]
view NEAT report all NEAT reports about NEAT
close